Aesica Honoured with Prestigious Award
News Apr 11, 2016
Aesica Pharmaceuticals, the global pharmaceutical contract development and manufacturing organisation (CDMO), has secured the 2016 NEPIC Young Achiever of the Year Accolade – making this the sixth time that the company has successfully secured this award in the space of a few years.
The NEPIC, the leading cluster organisation working with the chemical-using industries, including pharmaceuticals, located in the North East of England hub, bestows the award to young professionals in recognition of their achievement of career success through merit, knowledge, skills development and high endeavour.
This year’s winner is Lynsey Watson of Aesica Pharmaceuticals. Lynsey secured a Masters Degree in Medicinal Chemistry from Newcastle University. Post graduation, Lynsey commenced her career at NewChem Technologies as a research assistant, conducting custom- research and development of small molecules and early phase API’s - before returning to Newcastle University to undertake and successfully complete a PhD in Organic Chemistry in 2012.
She began work as a Level 2 chemist and in 2014 progressed to the position of a level 1 chemist – a role that incorporated greater responsibility, customer interaction and guiding numerous products from proof to concept or technical transfer through scale-up and full scale manufacture. The experience she gained proved invaluable and led to her role as project manager for new product introductions in 2015 – making her the youngest person in the history of Aesica to reach and hold a position at that level.“
Lynsey Watson commented: “I feel greatly honoured to have secured this award. The pharmaceutical manufacturing industry in the North East of England affords tremendous career opportunities for many graduates and aspiring young recruits in this field. Indeed, I especially look forward to continuing to play my part in the success of Aesica – working within the company at its world class facilities that deliver high value services from within the North East’s flourishing pharmaceutical manufacturing hub.”
David Lloyd, HR Director at Aesica Pharmaceuticals commented: “We are delighted that for the sixth time, members of our talented staff have won this accolade from the NEPIC. Indeed, at Aesica, we see our skilled personnel as a critical resource that continues to contribute massively to the on-going growth of the company. We therefore nurture that talent and provide a solid career path that attracts such high calibre graduates and committed young professionals into the company in the first place.”
He continued: “We offer the opportunity to excel and achieve significant success and progression, both for themselves and indeed for the company itself. We provide highly structured, team orientated opportunities for such staff – enabling them to carry out quality, value enhancing work across a number of the wide variety of formulation, development, manufacturing and packaging projects that we initiate from our international facilities, including those located in the North East of the U.K.”
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE